Dexmethsone

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Dexamethasone sodium phosphate 4.4mg equivalent to dexamethasone phosphate 4.0 mg

Disponibbli minn:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (Isem Internazzjonali):

Dexamethasone sodium phosphate 4.4 mg (equivalent to dexamethasone phosphate 4.0 mg)

Dożaġġ:

4 mg/mL

Għamla farmaċewtika:

Solution for injection

Kompożizzjoni:

Active: Dexamethasone sodium phosphate 4.4mg equivalent to dexamethasone phosphate 4.0 mg Excipient: Creatinine Sodium citrate Water for injection

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Sanofi Chimie

Indikazzjonijiet terapewtiċi:

Replacement Therapy Adrenocortical Insufficiency Dexamethasone has predominantly glucocorticoid activity and, therefore, is not a complete replacement therapy in cases of adrenocortical insufficiency. Dexamethasone should be supplemented with salt and/or a mineralocorticoid, such as deoxycorticosterone. When so supplemented, dexamethasone is indicated in the following: · Acute adrenocortical insufficiency · Addison's disease · Bilateral adrenalectomy · Relative adrenocortical insufficiency · Primary and secondary adrenocortical insufficiency Prolonged administration of adrenocortical steroids can produce dormancy of the adrenal cortex. The reduced secretory capacity gives rise to a state of relative adrenocortical insufficiency which persists for a varying length of time after therapy is discontinued. Should a patient be subjected to a sudden stress during this period of reduced secretion (for up to two years after therapy has ceased) the steroid output may not be adequate. Steroid therapy should, therefore, be reinstituted to help cope with stress such as that associated with surgery, trauma, burns or severe infections where specific antibiotic therapy is available.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Vial, glass, single dose, 5 x 1 ml type I, amber vial with grey chlorobutyl stopper - 5 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 5 x 2 ml type I, amber vial with grey chlorobutyl stopper - 10 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 10 x 1 ml type I, amber vial with grey chlorobutyl stopper - 10 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 10 x 2 ml type I, amber vial with grey chlorobutyl stopper - 20 mL - 12 months from date of manufacture stored at or below 25°C protect from light

Data ta 'l-awtorizzazzjoni:

2013-04-02